APA (7th ed.) Citation

A, P., M, F. P., N, C., LA, V., A, G., A, G., . . . A, G. R. (2024). Cost-benefit analysis of the National Immunization Program in Spain. Human vaccines & immunotherapeutics, 20(1), 2385175. https://doi.org/10.1080/21645515.2024.2385175

Chicago Style (17th ed.) Citation

A, Pérez, et al. "Cost-benefit Analysis of the National Immunization Program in Spain." Human Vaccines & Immunotherapeutics 20, no. 1 (2024): 2385175. https://doi.org/10.1080/21645515.2024.2385175.

MLA (9th ed.) Citation

A, Pérez, et al. "Cost-benefit Analysis of the National Immunization Program in Spain." Human Vaccines & Immunotherapeutics, vol. 20, no. 1, 2024, p. 2385175, https://doi.org/10.1080/21645515.2024.2385175.